EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -14.3% | 378 | 0.0% | 0.00% | – |
| Q2 2023 | $7 | -91.8% | 378 | -87.4% | 0.00% | -100.0% |
| Q1 2023 | $85 | -3.4% | 3,009 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $88 | -99.9% | 3,009 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $79,000 | -43.2% | 3,009 | +6.8% | 0.00% | 0.0% |
| Q1 2022 | $139,000 | -2.8% | 2,817 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $143,000 | -8.9% | 2,817 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $157,000 | +29.8% | 2,817 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $121,000 | +2.5% | 2,817 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $118,000 | -9.9% | 2,817 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $131,000 | +9.2% | 2,817 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $120,000 | -29.0% | 2,817 | -19.9% | 0.00% | -50.0% |
| Q2 2020 | $169,000 | +4.3% | 3,517 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $162,000 | -23.2% | 3,517 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $211,000 | +6.0% | 3,517 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $199,000 | +1.5% | 3,517 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $196,000 | +10.1% | 3,517 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $178,000 | +25.4% | 3,517 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $142,000 | -41.8% | 3,517 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $244,000 | -8.3% | 3,517 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $266,000 | +43.8% | 3,517 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $185,000 | -6.6% | 3,517 | -4.9% | 0.00% | 0.0% |
| Q4 2017 | $198,000 | -10.4% | 3,700 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $221,000 | -24.3% | 3,700 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $292,000 | -4.9% | 3,700 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $307,000 | +55.1% | 3,700 | +48.0% | 0.00% | +33.3% |
| Q4 2016 | $198,000 | +13.1% | 2,500 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $175,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |